Publication & Citation Trends
Most Cited Works
Publications
66 total
IMMUNOGENICITY OUTCOMES OF A RANDOMIZED, MULTICENTER, INTERVENTIONAL, FIRST-IN-HUMAN, PHASE 1/2A STUDY OF VAC52416 (EXPEC10V), A VACCINE CANDIDATE FOR THE PREVENTION OF INVASIVE ESCHERICHIA COLI DISEASE OA
Cited by 1
Semantic Scholar
CHARACTERIZATION OF BACTEREMIC AND NON-BACTEREMIC SYNDROMES OF INVASIVE ESCHERICHIA COLI DISEASE AMONG HOSPITALIZED ADULTS AGED ≥60 YEARS: FINDINGS FROM A PROSPECTIVE, MULTINATIONAL, OBSERVATIONAL STUDY (EXPECT-2) OA
Cited by 0
Semantic Scholar
Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60–85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study OA
Cited by 23
Semantic Scholar
Global Distribution of O Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Collected From the Blood of Patients With Bacteremia Across Multiple Surveillance Studies OA
Cited by 31
Semantic Scholar
Distribution of extraintestinal pathogenic Escherichia coli O-serotypes and antibiotic resistance in blood isolates collected from patients in a surveillance study in Japan. OA
Cited by 6
Semantic Scholar
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo OA
Cited by 19
Semantic Scholar
Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola OA
Cited by 18
Semantic Scholar
Research Topics
Escherichia coli research studies
(16)
Statistical Methods in Clinical Trials
(11)
Antibiotic Resistance in Bacteria
(10)
Urinary Tract Infections Management
(10)
Cancer Immunotherapy and Biomarkers
(9)
Frequent Co-Authors
Affiliations
University of Maryland, Baltimore
Janssen (Belgium)
GlaxoSmithKline (United Kingdom)
GlaxoSmithKline (Belgium)
Janssen (United Kingdom)